Meeting
2023 ASCO Genitourinary Cancers Symposium
Evaluation of ctDNA in patients with CRPC with pathogenic germline mutations in BRCA2.
Authors
Minqi Huang
Tulane University, New Orleans, LA
Minqi Huang , Ellen B. Jaeger , Sydney Caputo , Crystal Casado , Albert Jang , Patrick L Sweeney , Sree M Lanka , Kanika Gupta , Alexandra Lieberman , Jennifer Schwartz , Olivia Pocha , Maddie Hawkins , Patrick Miller , Jodi Lyn Layton , Brian E. Lewis , Pedro C. Barata , Elisa M. Ledet , A. Oliver Sartor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 253)
DOI
10.1200/JCO.2023.41.6_suppl.253
Abstract #
253
Poster Bd #
F20
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Evaluation of ctDNA alterations in mCRPC patients with germline pathogenic mutations.
First Author: Malcolm Light
Poster
2019 Genitourinary Cancers Symposium
DNA repair germline pathogenic mutation associations with treatment duration and family history in prostate cancer.
First Author: James Vu
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical and molecular features of ATM and BRCA2 mutations in metastatic prostate cancer.
First Author: Xiaolei Shi
Poster
2023 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller